Delivery Order SPE2DB22D3301-SPE2DB25FZ0VD
- Not listed
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $11,897.28 on August 20, 2025, by the Defense Logistics Agency's Medical Supply Chain division. This firm fixed price, non-set-aside delivery order is scheduled for completion by August 21, 2025, and represents a child award under the company's larger prime contract vehicle with DLA Troop Support Medical. The award is part of AmerisourceBergen's extensive federal pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $44,106.83 to AmerisourceBergen Drug Corp for 50 mg TANK ASEТМ kits on August 15, 2025, with an ultimate completion date of August 18, 2025. This firm fixed-price delivery order represents a non-set-aside award issued competitively to AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. The contract is structured as a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $13,630.63 by the Defense Logistics Agency's Medical Supply Chain on September 11, 2025, with an ultimate completion date of September 12, 2025. The award is a firm fixed price, non-set-aside contract executed under a competitively awarded vehicle, with performance taking place at the awardee's Corporate Office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a $16,586.58 delivery order to AmerisourceBergen Drug Corp on August 11, 2025, with completion expected by August 12, 2025. This competitive, non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger pharmaceutical supply agreements. The award is directed to the company's corporate office located in Conshohocken, Pennsylvania, where the company maintains its primary operations as...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $19,820.16 to AmerisourceBergen Drug Corp on September 4, 2025, with an ultimate completion date of September 5, 2025. This firm fixed-price delivery order, which is not set-aside, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The vendor, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $61,470.05 by the Defense Logistics Agency's Medical Supply Chain on August 4, 2025, with an ultimate completion date of August 5, 2025. This firm fixed-price contract represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award was made...
- The U.S. Defense Logistics Agency (DLA), through its Medical Supply Chain division, awarded a delivery order valued at $16,589.43 to AmerisourceBergen Drug Corp on August 5, 2025, with an ultimate completion date of August 6, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $1,651.68 by the Defense Logistics Agency's Medical Supply Chain on September 3, 2025, with an ultimate completion date of September 4, 2025. This firm fixed price, non-set-aside contract is a child order issued under a larger contract vehicle and represents a competitive award to the pharmaceutical distributor. The delivery order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency Medical Supply Chain awarded a $22,129.63 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 19, 2025, with an ultimate completion date of August 20, 2025. This non-set-aside competitive award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery order will be performed at AmerisourceBergen's...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $44,421.83 by the Defense Logistics Agency's Medical Supply Chain on September 3, 2025, with an ultimate completion date of the same day. This competitively awarded, non-set-aside contract employs firm fixed-price pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The contract is...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB25FZ0VDDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $29,319.36 to AmerisourceBergen Drug Corp for the supply of 50 mg Tanase kits under a firm fixed price contract. The award was made on September 11, 2025, with an ultimate completion date of September 12, 2025. This non-set-aside award represents a competitive procurement conducted through an existing contract vehicle, with the place of performance located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. As a prime pharmaceutical vendor for the DLA Medical Supply Chain, AmerisourceBergen supplies a comprehensive portfolio of pharmaceutical products and medical supplies to support military healthcare systems and other federal health agencies worldwide. The company's demonstrated capability to fulfill competitive federal procurement requirements across diverse therapeutic domains and order values positions it as a critical distributor within the federal medical procurement ecosystem, supporting Defense Health Agency requirements and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $29.3k | 9/11/25 |